[Federal Register Volume 65, Number 114 (Tuesday, June 13, 2000)]
[Notices]
[Page 37154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-14944]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6:30 p.m., June 21, 2000. 8 a.m.-4:30 
p.m., June 22, 2000.
    Place: Four Points Hotel by Sheraton, 1850 Cotillion Drive, 
Atlanta, Georgia 30338.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. Sec. 1396s, the Committee is mandated to establish 
and periodically review and, as appropriate, revise the list of 
vaccines for administration to vaccine-eligible children through the 
Vaccines for Children (VFC) program, along with schedules regarding 
the appropriate periodicity, dosage, and contraindications 
applicable to the vaccines.
    Matters To Be Discussed: The agenda will include a discussion on 
the ACIP policies and procedures; ACIP recommendations for the 
pneumococcal conjugate vaccine; vaccine additive: aluminum update; 
vaccine additive: thimerosal; vaccines and autism; bioterrorism 
working group; general recommendations; anaphylaxis after MMR due to 
gelatin; progress report on vaccine identification standards 
initiative; status of high-speed needle-free jet injectors for mass 
vaccination campaigns; update on Geneva meeting on rotavirus 
vaccination; Vaccines for Children program update; adult working 
group: pneumococcal polysaccharide update; CDC/FDA report on two 
dose schedule for hepatitis B for adolescent; update on influenza 
vaccine supply; Global Alliance for Vaccines and Immunization: 
progress in supporting global immunization programs and introduction 
of new vaccines; Nabi an update from the Food and Drug 
Administration; update from the National Center for Infectious 
Diseases; update from the National Immunization Program; update from 
the Vaccine Injury Compensation Program; update from the National 
Vaccine Program. Other matters of relevance among the committee's 
objectives may be discussed.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


    Dated: June 8, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 00-14944 Filed 6-12-00; 8:45 am]
BILLING CODE 4163-18-P